So far, the greater effect of RG7388 is evidenced by the elevation of PARP cleavage that coincides well with increases in the levels of Bax and Bak, suggesting activation of the intrinsic pathway by this MDM2 inhibitor leading to apoptotic cell death in the cancer cells. The gene discussed is MDM2; the disease is cancer.